Human hybridoma cell lines secreting IgG specific for the major allerg
en in the pollen of short ragweed, Amb a I, were established from pati
ents who had been receiving antigen injections for immunotherapy. Reco
mbinant Ig genes were then constructed by cloning the heavy and light
chain variable region genes of the human hybridoma cell line and joini
ng them to the human alpha or kappa constant region genes in mammalian
expression vectors. Amb a I-specific IgA was expressed in two mouse m
yeloma cell lines, NS0 and Sp2/0. In both systems, transfected alpha a
nd kappa chains were assembled into IgA monomers or into dimers covale
ntly linked by the endogenous murine J chains. We propose that recombi
nant IgA monoclonal antibodies specific for airborne allergens may be
applied to the mucosal surface of the nasal linings or of the lower ai
rway of sensitized individuals to inhibit the entry of allergenic mole
cules across the mucosal epithelium and, therefore, to prevent the dev
elopment of allergic responses.